The Shotlee Journal
Browse Shotlee articles about Ozempic.
Showing 9 / 1083 Ozempic articles
Weight-loss medications are causing a recognizable 'Ozempic face,' characterized by gauntness and premature aging. Skincare brands are formulating serums to counteract these effects, but dermatologists are divided on their necessity and efficacy. Experts emphasize distinguishing science-based solutions from marketing.
Shares of Novo Nordisk have decreased substantially. This drop is influenced by increased competition in the GLP-1 market and a revised outlook for future growth. The global drugmaker faces headwinds from competitors like Eli Lilly.
A retrospective cohort study revealed that women taking GLP-1 receptor agonists before pregnancy exhibited a lower incidence of gestational diabetes. However, the study also indicated a potentially higher risk of pre-eclampsia in this group. These findings warrant further investigation due to the small sample size and potential confounding factors.
This article explores the potential effects of Ozempic on bone health during weight loss. While Ozempic itself may not directly cause bone loss, the weight loss it induces can affect bone density. Learn how to protect your bones with proper nutrition and exercise.
This article examines the emerging trend of microdosing GLP-1 medications like Mounjaro for various health conditions. It delves into personal experiences, potential benefits, and expert warnings regarding unsupervised use.
Michael McIntyre recently showcased his weight loss transformation in London, attributing it to the use of Mounjaro. He openly discussed his journey, including initial reluctance and subsequent positive results. He also commented on others using similar methods.
The Phase III OASIS 4 trial revealed that Novo Nordisk's oral Wegovy (semaglutide) reduced cardiovascular risk factors in individuals with obesity. The study supports the drug's approval, showing improvements in C-reactive protein and serum triglycerides. Blood sugar control also improved among patients.
Ashley Dupré has publicly apologized to Cheryl Burke after making critical comments about the DWTS judge's appearance. The apology follows backlash for body-shaming remarks made during a TikTok video. Dupré acknowledged her comments were insensitive and apologized for her actions.
Dominic Cummings' vision for a groundbreaking research agency is gaining momentum with cross-party support and substantial funding. ARIA aims to revolutionize the UK through cutting-edge technologies and entrepreneurial science, seeking its own 'Ozempic moment'.
